Cryo-Cell is a leader in cord blood research and holds more cord blood patents, through its research affiliate, than any other cord blood bank. Its research partners include Stanford University, Saneron-CCEL Therapeutics and many other leading scientific institutions. Cryo-Cell supports research projects that address a broad range of diseases.
Cryo-Cell’s laboratory, medical, and scientific team is led by Dr. Linda Kelley
. (See below for Dr. Kelley’s credentials.) Should there ever be a medical need, Cryo-cell’s clients have the assurance that Dr. Kelley and her team will be by their side to offer advice and support.
Collection, Processing, Cryopreservation Methods
Facility, Guarantees, and Accreditation
Cryo-Cell’s collection kit safeguards stem cells during transport approximately 30 times longer than other private cord blood banks when exposed to extreme temperatures.
To maximize the recovery of stem cells, Cryo-Cell’s laboratory technologists separate stem cells from cord blood using PrepaCyte® CB, the most advanced processing technology in the field. This method depletes up to 99% of the red blood cells and recovers the highest number of Colony-forming Units, which are the stem cells that are the best predictor of patient outcomes.
Cryo-Cell has the only FDA NDA approved collection bag in the industry. Following the FDA recommendation, it uses heparin-free bags to safeguard clients from complications linked to heparin toxicity and allergy reaction, as well as to maximize the recovery of stem cells . The bag is also sterile and C-Section ready.
Cryo-Cell’s cord tissue collection cup contains sterile saline solution, combined with antibiotics, to best preserve and protect the specimens during transport. Since many cutting edge new studies show that regenerative medicine is most effective with a mix of stem cell types (simulating the team work taking place within our organs and tissues), Cryo-Cell stores the umbilical cord tissue in its entirety to preserve all its cell types to maximize donors’ future health options.
Cryo-Cell implements the most stringent cryopreservation process. All specimens are overwrapped with an extra layer of protection to avoid cross contamination before being stored in the vapor phase of liquid nitrogen within closely monitored cryogenic freezers, where the temperature is maintained at approximately -196oC.
Dr. Linda Kelley, Chief Scientific Officer of Cryo-Cell
Cryo-Cell’s state-of-the-art laboratory and storage facility are situated adjacent to its corporate headquarters. This proximity allows its executives to directly oversee the daily operation of the most secured, efficient, and technically advanced facility.
Cryo-Cell offers the industry’s best $75,000 Cryo-Cell Payment Guarantee and $10,000 Cryo-Cell Cares Payment Program, designed to help clients defray the cost of stem cell transplants should the need arise.
Cryo-Cell’s facility is accredited by AABB, the first U.S. (for private use only) cord blood bank to receive FACT accreditation, registered with the FDA, cGMP-/cGTP-compliant and ISO 9001:2008 certified.
Dr. Linda Kelley, an expert on stem cell transplantation and regenerative medicine, was the director of the Connell O’Reilly Cell Manipulation Core Facility of Dana-Farber Cancer Institute at Harvard. Widely recognized as the world’s preeminent auditor of cord blood laboratories, Dr. Kelley has served on boards and committees that establish standards and regulations for the cellular therapy field and recently was the Chairwoman for the Standards Committee of FACT (The Foundation for the Accreditation of Cellular Therapy). Dr. Kelley is always forward thinking and attentive to the processes and technologies deployed in the lab, and she is also well connected and respected in the stem cell and cancer research communities to preview and influence current and future research directions.
1Recommended in U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. Guidance for Industry: Minimally Manipulated, Unrelated, Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution for Specified Indications, published October 2009. It states, “During collection of cord blood, we recommend that you use an appropriate closed, sterile container sealed in a manner that prevents cell loss and contamination. We recommend that you use only citrate-based anticoagulants.”
2Publication discussing benefit of CPD as compared to Heparin: Blood (ASH Annual Meeting Abstracts) American Society of Hematology “Cord Blood Units Collected with Liquid CPD Appear to Contain Significantly More Nucleated and CD34+ Cells Than Units Collected with Dry Heparin” Morey Kraus*, 1, Karen Foster*, 2, Asimena Rigas Bridges*, 3 and Mark C. Walters, MD 4 2009 114: Abstract 4227 http://abstracts.hematologylibrary.org/cgi/content/abstract/114/22/4227
Features and Pricing
and financing options
ways to enroll
Learn how to safeguard
life-saving stem cells